FDA Approval of Remdesivir — A Step in the Right Direction | NEJM
Perspective from The New England Journal of Medicine — FDA Approval of Remdesivir — A Step in the Right Direction
Related Articles
The gut microbiome associates with phenotypic manifestations of post-acute COVID-19 syndrome
Current understanding of the heterogeneity of post-acute COVID-19 syndrome (PACS) is limited. Examining the fecal microbiome in subjects with PACS, Su et al. uncover an association…
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Our findings suggest that residual SARS-CoV-2 can persist in patients who have recovered from mild COVID-19 and that there is a significant association between viral…
Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract | Proceedings of the National Academy of Sciences
Respiratory virus infections in humans cause a broad-spectrum of diseases that result in substantial morbidity and mortality annually worldwide. To…
Body mass index–dependent shifts along large-scale gradients in human cortical organization explain dietary regulatory success | Proceedings of the National Academy of Sciences
Making healthy dietary choices is essential for keeping weight within a normal range. Yet many people struggle with dietary self-control despite go…
Covid levels remain low but new variants are coming, as is bird flu
There is a lot less Covid data around now, but what there is shows that levels of Covid remain low in the UK. That said,…
GLP-1 Receptor Agonist Use and Risk of Postoperative Complications
This cohort study evaluates the risk of postoperative respiratory complications among patients with diabetes undergoing surgery who had vs those who had not a prescription…
Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence
Nature Microbiology – Targeted accurate RNA consensus sequencing enables study of de novo errors caused by RNA-dependent RNA polymerases and provides deeper insights into how…
Mortality, Hospitalization, and Cardiac Interventions in Patients With Atrial Fibrillation Aged <65 Years
BACKGROUND: The risk factor (RF) burden, clinical course, and long-term outcome among patients with atrial fibrillation (AF) aged <65 years is unclear. METHODS: Adult (n=67 221;…
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events | NEJM
Original Article from The New England Journal of Medicine — Microplastics and Nanoplastics in Atheromas and Cardiovascular Events